The mouse and human data suggest that SPTBN1 and SMAD3 play critical roles not only in TGF-β signaling but also in mediating the inflammatory and tumor-promoting effects of a dysregulated gut microbiome. This evidence concerns the gene SPTBN1 and neoplasm.